Nothing Special   »   [go: up one dir, main page]

NO812542L - Nye trisubstituerte imidazolderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse samt deres anvendelse - Google Patents

Nye trisubstituerte imidazolderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse samt deres anvendelse

Info

Publication number
NO812542L
NO812542L NO812542A NO812542A NO812542L NO 812542 L NO812542 L NO 812542L NO 812542 A NO812542 A NO 812542A NO 812542 A NO812542 A NO 812542A NO 812542 L NO812542 L NO 812542L
Authority
NO
Norway
Prior art keywords
phenyl
formula
substituted
atoms
pyridyl
Prior art date
Application number
NO812542A
Other languages
English (en)
Norwegian (no)
Inventor
Alfred Sallmann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO812542L publication Critical patent/NO812542L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
NO812542A 1980-07-25 1981-07-24 Nye trisubstituerte imidazolderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse samt deres anvendelse NO812542L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH571580 1980-07-25

Publications (1)

Publication Number Publication Date
NO812542L true NO812542L (no) 1982-01-26

Family

ID=4298165

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812542A NO812542L (no) 1980-07-25 1981-07-24 Nye trisubstituerte imidazolderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse samt deres anvendelse

Country Status (23)

Country Link
US (1) US4447431A (fr)
EP (1) EP0045081B1 (fr)
JP (1) JPS5756466A (fr)
KR (13) KR850000883B1 (fr)
AR (1) AR230269A1 (fr)
AT (1) ATE17349T1 (fr)
AU (2) AU7340481A (fr)
CA (1) CA1175431A (fr)
DD (2) DD201677A5 (fr)
DE (1) DE3173434D1 (fr)
DK (1) DK331881A (fr)
ES (8) ES8301472A1 (fr)
FI (1) FI812326L (fr)
GB (1) GB2080805B (fr)
GR (1) GR75287B (fr)
IE (1) IE52071B1 (fr)
IL (1) IL63410A (fr)
NO (1) NO812542L (fr)
NZ (1) NZ197828A (fr)
PL (8) PL237002A1 (fr)
PT (1) PT73424B (fr)
SU (8) SU1235454A3 (fr)
ZA (1) ZA815078B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123831B (en) * 1981-07-20 1986-01-15 Ciba Geigy Ag Trisubstituted oxazo compounds
EP0084756A1 (fr) * 1982-01-22 1983-08-03 Ciba-Geigy Ag Dérivés oxaza trisubstitués
FR2633291B1 (fr) * 1988-06-27 1990-09-07 Oreal Derives d'hydroxy-4 isoxazoles, leur procede de preparation et compositions cosmetiques et pharmaceutiques les contenant
US5252322A (en) * 1989-09-22 1993-10-12 The Gillette Company Skin tanning compositions containing imidazoles
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
IL104369A0 (en) * 1992-01-13 1993-05-13 Smithkline Beecham Corp Novel compounds and compositions
US5916891A (en) 1992-01-13 1999-06-29 Smithkline Beecham Corporation Pyrimidinyl imidazoles
US5593992A (en) * 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
US5670527A (en) * 1993-07-16 1997-09-23 Smithkline Beecham Corporation Pyridyl imidazole compounds and compositions
US5593991A (en) * 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
WO1995013067A1 (fr) 1993-11-08 1995-05-18 Smithkline Beecham Corporation Oxazoles pour le traitement de maladies induites par la cytokine
US5723477A (en) * 1994-11-10 1998-03-03 Sibia Neurosciences, Inc. Modulators of acetylcholine receptors
US5658903A (en) * 1995-06-07 1997-08-19 Smithkline Beecham Corporation Imidazole compounds, compositions and use
US5739143A (en) * 1995-06-07 1998-04-14 Smithkline Beecham Corporation Imidazole compounds and compositions
US6369068B1 (en) 1995-06-07 2002-04-09 Smithkline Beecham Corporation Amino substituted pyrimidine containing compounds
ZA9610687B (en) * 1995-12-22 1997-09-29 Smithkline Beecham Corp Novel synthesis.
CZ216498A3 (cs) * 1996-01-11 1999-08-11 Smithkline Beecham Corporation Nové substituované imidazolové sloučeniny
AP9700912A0 (en) 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
ZA97175B (en) * 1996-01-11 1997-11-04 Smithkline Beecham Corp Novel substituted imidazole compounds.
US6046208A (en) * 1996-01-11 2000-04-04 Smithkline Beecham Corporation Substituted imidazole compounds
JP2000507558A (ja) * 1996-03-25 2000-06-20 スミスクライン・ビーチャム・コーポレイション Ｃｎｓ損傷についての新規な治療
EP0956018A4 (fr) 1996-08-21 2000-01-12 Smithkline Beecham Corp Composes d'imidazole, compositions les contenant et leur utilisation
US5929076A (en) * 1997-01-10 1999-07-27 Smithkline Beecham Corporation Cycloalkyl substituted imidazoles
CN1211381C (zh) * 1997-04-24 2005-07-20 奥索·麦克尼尔药品公司 用于治疗炎性疾病的取代咪唑
AU7966198A (en) 1997-06-13 1998-12-30 Smithkline Beecham Corporation Novel pyrazole and pyrazoline substituted compounds
EP0994870A4 (fr) 1997-06-19 2002-10-23 Smithkline Beecham Nouveaux composes imidazole a substitution d'aryloxypymiridine
AR016294A1 (es) * 1997-07-02 2001-07-04 Smithkline Beecham Corp Compuesto de imidazol sustituido, composicion farmaceutica que la contiene, su uso en la fabricacion de un medicamento y procedimiento para supreparacion
US6562832B1 (en) 1997-07-02 2003-05-13 Smithkline Beecham Corporation Substituted imidazole compounds
EP1019396A1 (fr) 1997-07-02 2000-07-19 SmithKline Beecham Corporation Nouveaux imidazoles cycloalkyle-substitues
TW517055B (en) 1997-07-02 2003-01-11 Smithkline Beecham Corp Novel substituted imidazole compounds
US7301021B2 (en) * 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
US6489325B1 (en) 1998-07-01 2002-12-03 Smithkline Beecham Corporation Substituted imidazole compounds
US6362193B1 (en) 1997-10-08 2002-03-26 Smithkline Beecham Corporation Cycloalkenyl substituted compounds
US6335340B1 (en) 1997-12-19 2002-01-01 Smithkline Beecham Corporation compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses
KR20010025087A (ko) 1998-05-22 2001-03-26 스튜어트 알. 수터 신규한 2-알킬 치환된 이미다졸 화합물
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
EP1112070B1 (fr) * 1998-08-20 2004-05-12 Smithkline Beecham Corporation Nouveaux composes de triazole substitues
AU1909200A (en) 1998-11-04 2000-05-22 Smithkline Beecham Corporation Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
WO2000029399A1 (fr) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Composes antiherpes
US6239279B1 (en) 1998-12-16 2001-05-29 Smithkline Beecham Corporation Synthesis for 4-aryl-5-pyrimidine imidazole substituted derivatives
DE60015594T2 (de) 1999-11-22 2005-10-27 Smithkline Beecham P.L.C., Brentford Imidazolderivate und deren verwendung als raf kinase inhibitoren
DE60023025T2 (de) 1999-11-23 2006-07-13 Smithkline Beecham Corp. 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
EP1233951B1 (fr) 1999-11-23 2005-06-01 SmithKline Beecham Corporation Composes de 3,4-dihydro-(1h)quinazolin-2-one utilises comme inhibiteurs de kinase csbp/p38
US6759410B1 (en) * 1999-11-23 2004-07-06 Smithline Beecham Corporation 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
ATE281439T1 (de) 1999-11-23 2004-11-15 Smithkline Beecham Corp 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
US7235551B2 (en) * 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
JP2003525936A (ja) * 2000-03-06 2003-09-02 スミスクライン ビーチャム パブリック リミテッド カンパニー Ｒａｆキナーゼ阻害物質としてのイミダゾール誘導体
GB0005357D0 (en) 2000-03-06 2000-04-26 Smithkline Beecham Plc Compounds
EP2404603A1 (fr) * 2000-10-23 2012-01-11 Glaxosmithkline LLC Nouveaux composés 8H-pyrido[2,3-d]pyrimidin-7-one trisubstituté pour le traitement des maladies faisant intervenir les kinases CSBP/p38.
GB0112348D0 (en) * 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
US20040192689A1 (en) * 2001-09-05 2004-09-30 Dean David Kenneth Heterocycle-carboxamide derivatives as raf kinase inhibitors
TW200505446A (en) * 2003-01-17 2005-02-16 Fuj Isawa Pharmaceutical Co Ltd Inhibitor of cox
WO2004099130A2 (fr) * 2003-05-08 2004-11-18 Astellas Pharma Inc. Inhibiteur de cox
AU2006229995A1 (en) * 2005-03-25 2006-10-05 Glaxo Group Limited Process for preparing pyrido(2,3-d)pyrimidin-7-one and 3,4-dihydropyrimido(4,5-d)pyrimidin-2(1H)-one derivatives
MY145343A (en) 2005-03-25 2012-01-31 Glaxo Group Ltd Novel compounds
WO2013049272A2 (fr) 2011-09-29 2013-04-04 Theraceutix, Llc Composition et méthode de traitement des symptômes associés à différentes affections cutanées

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558645A (en) * 1968-07-08 1971-01-26 Sandoz Ag 2-(4-(4',5-diphenyl - 2 - imidazolyl)-phenoxy) lower aliphatic monocarboxylic acids
CH561718A5 (fr) * 1971-05-10 1975-05-15 Ciba Geigy Ag
GB1469532A (en) * 1973-06-28 1977-04-06 Dumex Ltd As Imimdazolyl-alkanoic acid derivatives
US4372964A (en) * 1980-10-30 1983-02-08 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-1H-imidazole-2-methanols

Also Published As

Publication number Publication date
JPS5756466A (en) 1982-04-05
KR850002756A (ko) 1985-05-15
ES514579A0 (es) 1983-05-16
SU1205763A3 (ru) 1986-01-15
CA1175431A (fr) 1984-10-02
SU1152520A3 (en) 1985-04-23
FI812326L (fi) 1982-01-26
ES514583A0 (es) 1983-05-16
KR850000890B1 (ko) 1985-06-26
KR830006230A (ko) 1983-09-20
KR850000887B1 (ko) 1985-06-26
GB2080805A (en) 1982-02-10
ES8306123A1 (es) 1983-05-16
PL237003A1 (en) 1983-02-28
ES514582A0 (es) 1983-05-16
EP0045081B1 (fr) 1986-01-08
KR850002752A (ko) 1985-05-15
NZ197828A (en) 1985-11-08
GB2080805B (en) 1984-03-07
ES514580A0 (es) 1983-05-16
SU1227112A3 (ru) 1986-04-23
ES504257A0 (es) 1982-12-01
IL63410A0 (en) 1981-10-30
KR850000889B1 (ko) 1985-06-26
IL63410A (en) 1986-04-29
PL232352A1 (fr) 1982-12-20
IE52071B1 (en) 1987-06-10
ES8307245A1 (es) 1983-07-01
KR850002745A (ko) 1985-05-15
SU1205764A3 (ru) 1986-01-15
EP0045081A2 (fr) 1982-02-03
SU1138023A3 (ru) 1985-01-30
GR75287B (fr) 1984-07-13
AR230269A1 (es) 1984-03-01
KR850002755A (ko) 1985-05-15
US4447431A (en) 1984-05-08
KR850001064B1 (ko) 1985-07-25
DK331881A (da) 1982-01-26
PL237005A1 (en) 1983-02-28
ZA815078B (en) 1982-07-28
KR850000884B1 (ko) 1985-06-26
PL237001A1 (en) 1983-02-28
ATE17349T1 (de) 1986-01-15
PL236997A1 (en) 1983-01-03
AU7340481A (en) 1982-01-28
ES514584A0 (es) 1983-05-16
IE811680L (en) 1982-01-25
KR850002747A (ko) 1985-05-15
ES514585A0 (es) 1983-07-01
KR850000911B1 (ko) 1985-06-27
PT73424A (en) 1981-08-01
PL237004A1 (en) 1983-02-28
KR850000883B1 (ko) 1985-06-26
KR850002750A (ko) 1985-05-15
KR850002748A (ko) 1985-05-15
DD201677A5 (de) 1983-08-03
ES514581A0 (es) 1983-05-16
KR850000873B1 (ko) 1985-06-22
PT73424B (en) 1983-06-20
ES8306120A1 (es) 1983-05-16
KR850002753A (ko) 1985-05-15
EP0045081A3 (en) 1982-04-07
KR850000891B1 (ko) 1985-06-26
ES8306121A1 (es) 1983-05-16
ES8306122A1 (es) 1983-05-16
KR850002749A (ko) 1985-05-15
ES8306119A1 (es) 1983-05-16
DE3173434D1 (en) 1986-02-20
KR850000885B1 (ko) 1985-06-26
DD202554A5 (de) 1983-09-21
KR850002744A (ko) 1985-05-15
KR850000886B1 (ko) 1985-06-26
SU1169534A3 (ru) 1985-07-23
KR850002754A (ko) 1985-05-15
KR850000892B1 (ko) 1985-06-26
SU1145928A3 (ru) 1985-03-15
AU5655586A (en) 1986-09-11
KR850000888B1 (ko) 1985-06-26
PL237000A1 (en) 1983-02-28
ES8301472A1 (es) 1982-12-01
SU1235454A3 (ru) 1986-05-30
KR850002746A (ko) 1985-05-15
ES8306124A1 (es) 1983-05-16
PL135822B1 (en) 1985-12-31
PL237002A1 (en) 1983-02-28

Similar Documents

Publication Publication Date Title
NO812542L (no) Nye trisubstituerte imidazolderivater, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse samt deres anvendelse
KR900008566B1 (ko) 치환된 바이시클릭 화합물의 제조방법
EP0533837A1 (fr) Inhibition de maladies induites par des voies de 5-lipoxygenase et de cyclooxygenase
AU778819B2 (en) 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
US4711903A (en) Phenolic thioethers as inhibitors of 5-lipoxygenase
BRPI0618354A2 (pt) composto ou seu sal farmaceuticamente aceitável, antagonista do receptor-3 de histamina, agonista inverso do receptor-3 de histamina, preventivo ou remédio
US6900232B2 (en) Cycloalkyl alkanoic acids as integrin receptor antagonists
NO862618L (no) Nye pikolinderivater, fremgangsmaate ved fremstilling derav, anvendelse og medikamenter som inneholder dem.
NZ238576A (en) Pyridinone derivatives, preparation and pharmaceutical compositions thereof
JPH0153671B2 (fr)
TW201422586A (zh) 經取代４－吡啶酮及其做爲嗜中性白血球彈性蛋白酶活性抑制劑之用途
JPH05178840A (ja) ピリミジンの新誘導体、それらの製造法、得られる中間体、それらの薬剤としての使用及びそれらを含有する製薬組成物
JP4166991B2 (ja) ピリドピリミジンまたはナフチリジン誘導体
US20220241425A1 (en) Small molecule target bromo/acetyl proteins and uses thereof
JPH0471077B2 (fr)
NZ194328A (en) 3-amino-1-(phenyl or pyridyl)-2-pyrazolines:pharmaceutical compositions
US4694018A (en) Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives
US7064207B2 (en) Androgen receptor antagonists
KR100273181B1 (ko) 신규 피리돈 유도체 그의 제조방법 그에 의해 얻어진 신규 중간체, 그의 의약으로서의 용도 및 그를 함유하는 제약 조성물
JP2006520780A (ja) アンドロゲン受容体アンタゴニストとしてのキノリンおよびクロメンの６−スルホンアミド誘導体
JP3637961B2 (ja) 芳香族含窒素六員環化合物
JPH06157543A (ja) 新規のチエノチアジン誘導体、その製造方法並びにその使用方法
NO812790L (no) Nye diaryl-imidazol-forbindelser, fremgangsmaate til deres fremstilling, farmasoeytiske preparater som inneholder disse og deres anvendelse
US3700691A (en) 3,3-disubstituted-3,4-dihydrobenzodioxepins
DK160049B (da) 6-phenethylaminoalkyl-furo-(3,4-c)-pyridin-derivater, og laegemidler indeholdende saadanne forbindelser